Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells

British Journal of Cancer

Volumn 101, Issue 9, 2009, Pages 1613-1619

  Martinez Campa C ^a   Gonzalez A ^a   Mediavilla, M D ^a   Alonso Gonzalez C ^a   Alvarez Garcia V ^a   Sanchez Barcelo E J ^a   Cos, S ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Aromatase; Breast cancer; MCF 7 cells; Melatonin; Pineal

Indexed keywords

AROMATASE; CYCLIC AMP; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MELATONIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2;

ARTICLE; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

AROMATASE; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLIC AMP; DINOPROSTONE; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MELATONIN; PROMOTER REGIONS, GENETIC; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER;

EID: 70350646913     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605336     Document Type: Article

References (42)

1. Ackerman GE, Smith ME, Mendelson CR, MacDonald PC, Simpson ER (1981) Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J Clin Endocrinol Metab 53: 412-417
2. Blask DE, Hill SM (1986) Effects of melatonin on cancer: studies on MCF-7 human breast cancer cells in culture. J Neural Transm (Suppl) 21: 433-449
3. Blask DE, Sauer LA, Dauchy RT (2002) Melatonin as a chronobiotic/ anticancer agent: cellular, biochemical and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Topics Med Chem 2: 113-132
4. Bulun SE, Lin Z, Imir G, Amin S, Demura M, Yilmaz B, Martin R, Utsunomiya H, Thung S, Gurates B, Tamura M, Langoi D, Deb S (2005) Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev 57: 359-383
5. Cardinali DP, Bonanni Rey RA, Mediavilla MD, Sánchez- Barceló EJ (1992) Diurnal changes in cyclic nucleotide response to pineal indoles in murine mammary glands. J Pineal Res 13: 111-116
6. Chen D, Reierstad S, Lu M, Lin Z, Ishikawa H, Bulun SE (2009) Regulation of breast cancer-associated aromatase promoters. Cancer Lett 273: 15-27
7. Conley A, Hinshelwood M (2001) Mammalian aromatases. Reproduction 121: 685-695
8. Cos S, González A, Güezmes A, Mediavilla MD, Mart́inez-Campa C, Alonso-González C, Sánchez-Barceló EJ (2006a) Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity. Int J Cancer 118:274-278
9. Cos S, González A, Mart́inez-Campa C, Mediavilla MD, Alonso-González C, Sánchez-Barceló EJ (2006b) Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions. Cancer Detect Prev 30:118-128
10. Cos S, González A, Mart́inez-Campa C, Mediavilla MD, Alonso-González C, Sánchez-Barceló EJ (2008) Melatonin as a selective estrogen enzyme modulator. Curr Cancer Drug Tar 8: 691-702
11. Cos S, Mart́inez-Campa C, Mediavilla MD, Sánchez- Barceló EJ (2005) Melatonin modulates aromatase activity in MCF-7 human breast cancer cells. J Pineal Res 38: 136-142
12. Cos S, Sánchez-Barceló EJ (2000a) Melatonin and mammary pathological growth. Front Neuroendocrinol 21: 133-170
13. Cos S, Sánchez-Barceló EJ (2000b) Melatonin, experimental basis for a possible application in breast cancer prevention and treatment. Histol Histopathol 15: 637-647
14. De la Rocha N, Rotelli A, Aguilar CF, Pelzer L (2007) Structural basis of the anti-inflammatory activity of melatonin. Arzneimittel-Forsch 57:782-786
15. Del Rio B, Garćia-Pedrero JM, Mart́inez-Campa C, Zuazua P, Lazo PS, Ramos S (2004) Melatonin: an endogenous specific inhibitor of estrogen receptor a via calmodulin. J Biol Chem 279: 38294-38302
16. D́iaz-Cruz ES, Shapiro CL, Brueggemeier RW (2005) Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells. J Clin Endocrinol Metab 90: 2563-2570
17. Erovic BM, Woegerbauer M, Pammer J, Selzer E, Grasi MCh, Thurnher D (2008) Strong evidence for up-regulation of cyclooxigenase-1 in head and neck cancer. Eur J Clin Invest 38: 61-66
18. Esposito E, Iacono A, Muià C, Crisafulli C, Mattace Raso G, Bramanti P, Meli R, Cuzzocrea S (2008) Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells. J Pineal Res 44: 78-87
19. Godson C, Reppert SM (1997) The mel1a melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology 138: 397-404
20. González A, Cos S, Mart́inez-Campa C, Alonso-González C, Sánchez-Mateos S, Mediavilla MD, Sánchez-Barceló EJ (2008) Selective estrogen enzime modulator (SEEM) actions of melatonin in human breast cancer cells. J Pineal Res 45: 86-92
21. González A, Mart́inez-Campa C, Mediavilla MD, Alonso-González C, Sánchez-Mateos S, Hill SM, Sanchez- Barceló EJ, Cos S (2007) Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells. Oncol Rep 17: 947-955
22. Hill SM, Blask DE (1988) Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 48: 6121-6126
23. Hwang D, Scollard D, Byrne J, Levine E (1998) Expression of cycloox-ygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 90: 455-460
24. Kiefer T, Ram PT, Yuan L, Hill SM (2002) Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells. Breast Cancer Res Treat 71: 37-45
25. Kiefer TL, Lai L, Yuan L, Dong C, Burow ME, Hill SM (2005) Differential regulation of estrogen receptor alpha, glucocoticod receptor and retinoic acid receptor alpha transcriptional activity by melatonin is mediated via different G proteins. J Pineal Res 38: 231-239
26. Landeghem AA, Poortman J, Nabuurs M, Thijssen JH (1985) Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res 45: 2900-2906 (Pubitemid 15232767)
27. Liu X-H, Rose DP (1996) Differential expression and regulation of cyclooxygenase-1 and-2 in two human breast cancer cell lines. Cancer Res 56: 5125-5127
28. Mayo JC, Sainz RM, Tan D-X, Hardeland R, Leon J, Rodŕiguez C, Reiter RJ (2005) Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol 165: 139-149
29. Pasqualini JR (2004) The selective estrogen enzyme modulators in breast cancer: a review. Biochim Biophys Acta 1654: 123-143
30. Pasqualini JR, Chetrite GS (2005) Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J Steroid Biochem Mol Biol 93: 221-236
31. Prosperi JR, Robertson FM (2006) Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells. Prostag Oth Lipid M 81: 55-70
32. Ram PT, Dai J, Yuan L, Dong C, Kiefer TL, Lai L, Hill SM (2002) Involvement of the MT-1 melatonin receptor in human breast cancer. Cancer Lett 179: 141-150
33. Ram PT, Kiefer T, Silverman M, Song Y, Brown GM, Hill SM (1998) Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. Mol Cell Endocrinol 141: 53-64
34. Russo IH, Russo J (1998) Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia 3: 49-61
35. Santen RJ, Harvey HA (1999) Use of aromatase inhibitors in breast carcinoma. Endocr Relat Cancer 6: 75-92
36. Simpson ER (2000) Role of aromatase in sex steroid action. J Mol Endocrinol 25: 149-156
37. Sonne-Hansen K, Lykkesfeldt AE (2005) Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line. J Steroid Biochem Mol Biol 93: 25-34
38. Suzuki T, Miki Y, Nakamura Y, Moriya T, Ito K, Ohuchi N, Sasano H (2005) Sex steroid-producing enzymes in human breast cancer. Endocr-Relat Cancer 12: 701-720 (Pubitemid 41815772)
39. Wong ZW, Ellis MJ (2004) First-line endocrine treatment of breast cancer: aromatase inhibitor or antiestrogen? Br J Cancer 90: 20-25
40. Wu KK (2005) Control of cyclooxygenase-2 transcriptional activation by pro-inflammatory mediators. Prostag Leukotr Ess 72: 89-93
41. Yue W, Wang JP, Hamilton CJ, Demers LM, Santen RJ (1998) In situ aromatization enhances breast tumor estradiol levels and cellular proliferation. Cancer Res 58: 927-932
42. Zhou D, Wang J, Chen E, Murai J, Siiteri PK, Chen S (1993) Aromatase gene is amplified in MCF-7 human breast cancer cells. J Steroid Biochem Mol Biol 46: 147-153